Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

The guideline provides recommendations for managing alopecia areata effectively.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Alopecia areata is an autoimmune condition causing patchy hair loss, with treatments focusing on immune system regulation and hair regrowth.

Alopecia areata causes sudden, patchy hair loss due to immune system attacks on hair follicles.

Alopecia areata causes sudden, patchy hair loss due to an immune attack on hair follicles.

Alopecia areata causes sudden, patchy hair loss due to immune system attacks on hair follicles.

Alopecia areata causes sudden, patchy hair loss due to immune system attacks on hair follicles.

Alopecia areata causes sudden, patchy hair loss due to an immune attack on hair follicles.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

Tofacitinib is an effective and safe treatment for alopecia areata.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Modern treatments can effectively regrow hair and improve life for people with alopecia areata.

Nivolumab can cause hair loss as a rare side effect.

Alopecia areata can sometimes appear as a straight line of hair loss instead of round patches.

Alopecia areata is linked to blood cancers, especially in older patients, but not to most solid cancers.

Alopecia areata in children shows varied forms and treatment challenges, with some achieving full or partial hair regrowth.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Alopecia areata may increase the risk of cardiovascular disease.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

308 nm excimer lamp therapy is effective for alopecia areata but less so for severe cases.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

Low-dose intermittent corticosteroid therapy can effectively treat alopecia areata.

People with alopecia areata have a higher risk of heart disease.

Alopecia areata patients, especially with severe forms, have a higher risk of cardiovascular disease.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Baricitinib improved hair loss and arthritis in a lupus patient.

A new mix of anthralin and calcipotriene might help treat severe hair loss.